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We hereby report on the audiological and genetic 
findings in individuals from a Brazilian family, with the 
following mitochondrial mutation A1555G in the 12SrRNA 
gene (MT-RNR-1). Nine individuals underwent speech, 
audiologic (tonal audiometry and logoaudiometry) and 
genetic evaluations. Eight individuals among the A1555G 
carriers were affected by hearing impairment and one person 
had normal hearing thresholds till the end of the present 
study. The audiologic evaluation results indicated normal 
hearing thresholds all the way to bilateral profound hearing 
loss with post-lingual onset and variable configuration. Two 
affected siblings presented progressive hearing loss. It was 
impossible to precise the time of hearing loss onset; however, 
the impairment was present in both children and adults. The 
genetic study revealed the A1555G mitochondrial mutation 
Keywords: genetics, mitochondrial inheritance, hearing loss, 
nonsyndromic hereditary deafness.
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INTRODUCTION
It is estimated that 16% of the hearing loss cases in 
Brazil have confirmed genetic origins, while 70% of the 
patients have non-syndromic hearing loss. Recessive auto-
somal inheritance accounts for 80% of the non-syndromic 
inherited hearing loss cases; dominant autosomal patterns 
are seen in 10% to 20% of the cases; 2-3% of the cases are 
connected to chromosome X; and mitochondrial inheri-
tance occurs in only 1% of the patients1. Non-syndromic 
sensorineural hearing loss is a challenging condition for 
physicians, audiologists, and geneticists. Etiologic diagno-
sis is hard to reach, and the condition is not accompanied 
by physical traits indicative of genetic inheritance. A high 
degree of clinical suspicion and comprehensive infor-
mation on the patient’s family end up being required to 
properly diagnose and approach the condition.
Mitochondrial DNA mutations and deletions have 
been identified in non-syndromic sensorineural hearing 
loss patients. The mutation most commonly associated 
with maternal inheritance is A1555G on gene 12S rRNA, 
a relatively frequent finding among Asians. This mutation 
is found in approximately 3% of the Japanese, 5.3% of 
Indonesian and 0.5-2.4% of the European patients with 
sensorineural hearing loss 2.
The pathogenesis of this mutation is still largely unk-
nown, despite the various papers in the literature published 
on the matter3. In non-syndromic patients, mitochondrial 
sensorineural hearing loss is the only present symptom. 
Some authors have reported on the correlation between 
this condition and hypersensitivity to aminoglycosides1,4. In 
the United States, this mutation has been found in 15% of 
the patients with aminoglycoside-induced hearing loss5.
Mutation A1555G has been described as the main 
cause of aminoglycoside-induced hearing loss2. The mi-
tochondrial DNA strips of 62 members of nine families 
with aminoglycoside-induced hearing loss patients were 
analyzed, and mutation A1555G on gene 12S rRNA was 
found in 20 members of five families. The authors con-
cluded that there is a correlation between audiovestibular 
alteration and genetic susceptibility to the aminoglycoside 
ototoxicity of 6.
A study on the audiological traits connected to 
mitochondrial DNA mutation in a Chinese family with 41 
hearing loss patients found that the condition was asso-
ciated with mitochondrial mutation A1555G on gene 12S 
rRNA. The patients had symmetric bilateral sensorineural 
hearing loss - often progressive - with wide variation on 
the time of onset. The authors also mentioned that envi-
ronmental factors may have had a determining role in the 
clinical manifestation of the mutation7.
The same audiological aspects were verified in 
another study that enrolled 21 Japanese families with this 
mutation. The authors also found that there were individual 
variations in the characteristics of the hearing loss, corre-
lation with permanent tinnitus, with and without history 
of taking aminoglycosides, and more severe hearing loss 
among patients who took the antibiotic drug8.
A similar study done in Calabria enrolled 55 mem-
bers of 6 families with the mutation. They were affected by 
non-syndromic, generally symmetric hearing loss involving 
mainly high frequencies. The disease varied from mild 
to moderate, and progressed slowly. Subjects previously 
treated with ototoxic drugs had severe hearing loss, and 
one of them was a deaf-mute9.
In a Danish population, the prevalence of senso-
rineural dysacusis related to alterations in mitochondrial 
DNA and the identified clinical signs indicated that hearing 
loss caused by this mutation has a wide range of pheno-
types in audiological traits such as hearing loss grade, 
manifestation, and time of onset10.
A study done in Brazil on the prevalence of A1555G 
mitochondrial mutation and other mutations on mito-
chondrial gene RNAtSer(UCN)(MT-RNR-1) enrolled 203 
individuals with hearing loss and found mutation A1555G 
in 2% (4 families) of the patients. Other mutations were 
not found in this study11,12.
From the above mentioned studies, the ones that 
looked into audiological tests shed light on information 
and issues yet unaddressed by Brazilian studies. They 
indicate, for instance, that by analyzing affected families 
we can gather a broader perspective on the audiological 
characteristics and their evolution, as well as possible 
environmental factors. This study aimed to describe the 
audiological and genetic findings pertaining to a Brazi-
lian family with mutation A1555G on mitochondrial gene 
12SrRNA.
CLINICAL CASES
This study describes a family of subjects affected 
by non-syndromic hearing loss characterized by patterns 
of mitochondrial inheritance. One of the patients (III-8) 
was seen by a speech therapist and was suspected to 
have inherited hearing loss. His family members were 
then invited to be clinically assessed. Nine individuals 
were examined by ENT, speech therapy, and audiology 
experts (tone audiometry, logoaudiometry, and BAEP in 
some cases) and underwent genetic testing. Other family 
members came only to perform genetic studies or for the 
described clinical exams. This study describes and analyzes 
the audiological findings of only the nine individuals that 
underwent the tests mentioned above, i.e., genetic tests 
and ENT, speech therapy, and audiological examination. 
This study was approved by the Ethics Committee for Re-
search with Human Beings at the Institute of Biomedical 
Sciences under permit 023/CEP.
Genetic studies included the analysis of DNA ex-
tracted from lymphocytes. PCR followed by DNA digestion 
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with restriction enzyme Hae III were used to search for 
mitochondrial mutation A1555G, as described by Estivill 
et al. (1998)13.
The speech therapy and audiological exams were 
done at the ENT outpatient ward at Universidade de São 
Paulo (USP) and at the clinic under the Division for Edu-
cation and Rehabilitation of Communication Disorders at 
Pontifícia Universidade Católica de São Paulo (DERDIC/
PUC-SP). Genetic tests were conducted at the Center for 
Human Genome Studies of the Department of Genetics 
and Evolutional Biology at IBUSP.
All family members who underwent DNA analysis 
were found to have mutation A1555G on mitochondrial 
DNA gene RNAr 12S (Fig. 1).
hearing within the speech frequency range. According to 
their parents, subject III-8 was born with good hearing 
and began to experience hearing loss at 4 years of age, 
while subject III-10 underwent audiological examination 
for the first time at the age of 5 years and 3 months for 
suspected hearing loss. The other subjects (I-2, II-3, II-5, 
II-7, II-9, and II-12) experienced hearing loss when they 
were adults.
Audiometric findings, considering the degree of 
hearing loss, indicated that clinical phenotypes varied quite 
Figure 1. Family 14682 genealogical diagram (A). The arrow indicated 
purpose. Individuals marked in black have variable grades of hearing 
loss. Individuals marked with a dash above their symbols went through 
speech and hearing evaluation. Subjects marked with an asterisk were 
tested and have mitochondrial DNA mutation A1555G. (B) Polyacrylami-
de gel after impregnation with silver nitrate showing band pattern after 
PCR product digestion with restriction enzyme Hae III: normal control 
samples have 2 bands - 216pb and 123pb; family members carrying 
mutation A1555G have 3 bands - 216pb, 93pb, and 30pb.
One of the subjects (III-9) had no audiological 
symptoms, i.e., had normal hearing by the time of the tests. 
The other eight family members had different grades of bi-
lateral, moderate to severe sensorineural hearing loss (Fig. 
2). The data on all nine subjects, logoaudiometry results, 
and clinical information - mainly the data connected to the 
development of linguistic skills - indicated the presence 
of post-lingual hearing disorder. Symmetric hearing loss 
was more prevalent, as seen in other studies7,9, except 
for subject II-12. Almost all hearing loss configurations - 
flat, low frequency, and high frequency - were seen. The 
high frequency type was nonetheless more prevalent than 
others, showing increased hearing involvement in high 
frequencies, as also seen in other studies8,9. The other test 
results matched the clinical information.
Audiological monitoring was done only for subjects 
III-8 and III-10 - two affected siblings - and their hearing 
loss was found to be worsening progressively. They had 
fluctuating, progressive hearing loss in both right and left 
ears (Fig. 3). Hearing loss progress findings are compatible 
with those seen in other studies7,8,9. The linguistic skills 
of the two affected siblings were not severely impaired, 
probably because their hearing loss was post-lingual, or 
because it was only a partial loss, this preserving their 
Figure 2. Audiometric profiles and logoaudiometry results of studied 
subjects.
Figure 3. Hearing loss progression of subjects III-8 and III-10 - Colored 
legends indicate subject age at the time of the examination.
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substantially among the members of the studied family. The 
cases of hearing loss ranged from moderate to severe and 
were all bilateral and post-lingual. As mentioned above, 
there was no prevalent time of onset. Many of the subjects 
affected at adult age had tinnitus, and those treated for it 
had unsatisfactory outcomes8.
We could not connect the onset or worsening of 
hearing loss symptoms to the administration of amino-
glycosides, as the subjects were unable to accurately report 
on the use of antibiotics.
Only one subject (II-3) with hearing loss had been 
previously exposed to occupational noise, one of the 
possible environmental factors leading to gene mutation 
expression7. Subject I-2 had mild hearing loss only at hi-
gher frequencies at 61 years of age, a condition possibly 
connected to presbycusis.
Subjects were informed of the importance of having 
their hearing status monitored and of the risks associated 
with taking aminoglycosides. Some started using hearing 
aids and greatly improved their oral communication skills 
and quality of life. The significant improvement in hea-
ring tone and vocal thresholds confirmed the presence of 
cochlear involvement and stressed the absence of central 
hearing pathway involvement among patients with mito-
chondrial DNA mutation hearing loss.
CLOSING REMARKS
Many studies have been produced to enhance the 
etiologic diagnosis of hearing loss. Technologic develop-
ments, new examination techniques, and genetic tests have 
allowed earlier and more accurate diagnosis, providing 
further clarification on the etiology of the condition.
Mitochondrial DNA mutations are an important 
cause of hearing loss. General practitioners should there-
fore be very careful when diagnosing the etiology of the 
condition, and use the valuable aid of genetic tests with 
that purpose. Clinical teams may thus assist in preventing 
the early onset and worsening of hearing loss cases, miti-
gating tinnitus prevalence, and advise patients on the risk 
of taking aminoglycosides and being exposed to noise for 
prolonged period of time.
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